30 g tube · Marketed by Canixa Life Sciences Pvt Ltd
Composition: Clobetasol (0.05% w/w) + Salicylic Acid (3% w/w) + Lactic Acid (3% w/w) + Urea (10% w/w)
A FirstCare pharmacist checks your prescription before this is sent.
Inclusive of all taxes
Sold and delivered by FirstCare Pharmacy
Psoriasis is a skin problem in which skin cells build up and form scales and dry patches which are itchy and painful. Applying Lozivate-MF Ointment helps manage psoriasis symptoms like itching, pain, redness, swelling or irritation. It also moisturizes the skin and makes it soft and smooth. Clean and dry the affected area before applying Lozivate-MF Ointment. Use it atleast 2-3 times a day or as prescribed. You may see change in your skin appearance after few weeks.
Eczema is a condition in which patches of skin swells and becomes dry, itchy, rough and red. Lozivate-MF Ointment moisturizes the skin and helps reduce dryness and itchiness. It also reduces swelling and redness at the affected area. Apply Lozivate-MF Ointment 1-2 times a day or as prescribed by your doctor. You might see an improvement in your skin after 2 to 3 weeks of treatment.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Clean and dry the affected area and gently massage the ointment.
Lozivate-MF Ointment is a combination of four medicines: Clobetasol, Salicylic Acid, Lactic Acid and Urea which treat eczema and psoriasis. Clobetasol is a steroid medicine. It blocks the production of certain chemical messengers (prostaglandins) that make the skin red, swollen and itchy. Salicylic Acid, Lactic Acid and Urea are keratolytic medicines which break down keratin clumps, remove dead skin cells and soften the skin. They also enhances the absorption of Clobetasol into the skin.
Alcohol
No interaction found/established
Pregnancy
The safety of Lozivate-MF Ointment during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and animal data on reproductive toxicity are insufficient. Your doctor will weigh the benefits and any potential risks before prescribing.
Breastfeeding
Available human data suggest that the drug does not pass into breast milk in clinically significant amounts and is unlikely to harm the infant.
Driving
No interaction found/established
Kidney
No interaction found/established
Liver
No interaction found/established
Store below 25°C
This information is for reference only. Use medicines only as your doctor advises.
Same composition and strength, cheapest first.